Two Sigma Securities, LLC Rigel Pharmaceuticals Inc Transaction History

Two Sigma Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $30,200 - $65,434	41,945 New	41,945 $60,000
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $36,013 - $57,622	28,811 New	28,811 $38,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $24,432 - $116,326	36,466 New	36,466 $41,000
Q3 2020 Nov 16, 2020	SELL	$1.78 - $4.13 $66,240 - $153,693	-37,214 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $52,471 - $76,288	37,214 New	37,214 $68,000
Q2 2019 Aug 14, 2019	SELL	$2.02 - $2.61 $31,934 - $41,261	-15,809 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.0 - $2.65 $18,850 - $24,976	-9,425 Reduced 37.35%	15,809 $41,000
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $22,470 - $36,298	-10,803 Reduced 29.98%	25,234 $58,000
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $93,696 - $129,372	36,037 New	36,037 $116,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.